Falk Hertwig

3.7k total citations
21 papers, 536 citations indexed

About

Falk Hertwig is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Falk Hertwig has authored 21 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Neurology and 8 papers in Cancer Research. Recurrent topics in Falk Hertwig's work include Neuroblastoma Research and Treatments (12 papers), Microtubule and mitosis dynamics (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Falk Hertwig is often cited by papers focused on Neuroblastoma Research and Treatments (12 papers), Microtubule and mitosis dynamics (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Falk Hertwig collaborates with scholars based in Germany, Sweden and United States. Falk Hertwig's co-authors include Ulrike A. Nuber, Elisabet Englund, Teona Roschupkina, Sten Eirik W. Jacobsen, Johan Bengzon, Denise Kottwitz, Christine Steinhoff, Matthias Fischer, Ruth Volland and Sandra Ackermann and has published in prestigious journals such as Nature Genetics, Blood and Cancer Research.

In The Last Decade

Falk Hertwig

20 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Falk Hertwig Germany 11 329 156 107 105 87 21 536
Beng-Ti Ang Singapore 11 390 1.2× 164 1.1× 92 0.9× 65 0.6× 76 0.9× 14 611
John Y.H. Kim United States 11 517 1.6× 133 0.9× 159 1.5× 37 0.4× 145 1.7× 15 675
Zulekha A. Qadeer United States 8 497 1.5× 62 0.4× 84 0.8× 59 0.6× 67 0.8× 8 621
Jan Gronych Germany 11 466 1.4× 138 0.9× 102 1.0× 27 0.3× 308 3.5× 17 706
Daniel Haag Germany 12 572 1.7× 95 0.6× 107 1.0× 90 0.9× 76 0.9× 15 791
Leire Moreno‐Cugnon Spain 12 311 0.9× 193 1.2× 86 0.8× 30 0.3× 140 1.6× 17 557
Edward Visse Sweden 16 242 0.7× 72 0.5× 247 2.3× 69 0.7× 269 3.1× 38 756
Kanae Mitsunaga Japan 13 746 2.3× 84 0.5× 108 1.0× 34 0.3× 56 0.6× 16 908
Laura A. Genovesi Australia 12 287 0.9× 111 0.7× 59 0.6× 33 0.3× 112 1.3× 15 439
Israel Ben‐Dor Israel 8 304 0.9× 36 0.2× 59 0.6× 60 0.6× 63 0.7× 9 472

Countries citing papers authored by Falk Hertwig

Since Specialization
Citations

This map shows the geographic impact of Falk Hertwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falk Hertwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falk Hertwig more than expected).

Fields of papers citing papers by Falk Hertwig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Falk Hertwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falk Hertwig. The network helps show where Falk Hertwig may publish in the future.

Co-authorship network of co-authors of Falk Hertwig

This figure shows the co-authorship network connecting the top 25 collaborators of Falk Hertwig. A scholar is included among the top collaborators of Falk Hertwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Falk Hertwig. Falk Hertwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sprüssel, Annika, Takayoshi Suzuki, Naoki Miyata, et al.. (2024). Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine. 13(20). 6081–6081.
2.
Rodríguez-Fos, Elias, Mercè Planas-Fèlix, Martin Burkert, et al.. (2023). Mutational topography reflects clinical neuroblastoma heterogeneity. Cell Genomics. 3(10). 100402–100402. 8 indexed citations
3.
Klinger, Bertram, Tommaso Mari, Joern Toedling, et al.. (2021). Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance. PLoS Computational Biology. 17(11). e1009515–e1009515. 5 indexed citations
4.
Rosswog, Carolina, Christoph Bartenhagen, Yvonne Kahlert, et al.. (2021). Chromothripsis followed by circular recombination drives oncogene amplification in human cancer. Nature Genetics. 53(12). 1673–1685. 71 indexed citations
5.
Klironomos, Filippos, Annika Winkler, Patrick Hundsdoerfer, et al.. (2019). Abstract 1820: Circular RNAs contribute to neuroblastoma pathogenesis. Cancer Research. 79(13_Supplement). 1820–1820. 1 indexed citations
6.
Szymansky, Annabell, Heathcliff Dorado García, Joern Toedling, et al.. (2018). Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma. Annals of Oncology. 29. iii12–iii13. 1 indexed citations
7.
Klarqvist, Marcus D. R., Ulrica Westermark, Ganna Oliynyk, et al.. (2016). Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients. Cell Reports. 16(4). 979–993. 20 indexed citations
8.
Braun, Sebastian, Falk Hertwig, Sara Nolbrant, et al.. (2016). The putative tumor suppressor gene EphA7 is a novel BMI-1 target. Oncotarget. 7(36). 58203–58217. 8 indexed citations
9.
Ikram, Fakhera, Sandra Ackermann, Yvonne Kahlert, et al.. (2015). Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma. Molecular Oncology. 10(2). 344–359. 31 indexed citations
10.
Dahlhaus, Meike, Andreas Burkovski, Falk Hertwig, et al.. (2015). Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma. Cancer Letters. 371(1). 79–89. 39 indexed citations
11.
Peifer, Martin, Frederik Roels, Falk Hertwig, et al.. (2015). Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Cancer Research. 75(15_Supplement). LB–210. 1 indexed citations
12.
Noack, Sandra, Elmar Willbold, Andreas Winkel, et al.. (2014). Periostin Secreted by Mesenchymal Stem Cells Supports Tendon Formation in an Ectopic Mouse Model. Stem Cells and Development. 23(16). 1844–1857. 30 indexed citations
13.
Theißen, Jessica, André Oberthuer, Ruth Volland, et al.. (2014). Chromosome 17/17q gain and unaltered profiles in high resolution array‐CGH are prognostically informative in neuroblastoma. Genes Chromosomes and Cancer. 53(8). 639–649. 27 indexed citations
14.
Ikram, Fakhera, Sarah E. Ackermann, Frederik Roels, et al.. (2014). 409 Transcription factor activating protein 2 beta (TFAP2B) mediates neuronal differentiation in neuroblastoma. European Journal of Cancer. 50. 130–131. 1 indexed citations
15.
Hertwig, Falk, Katharina Meyer, Sebastian Braun, et al.. (2012). Definition of Genetic Events Directing the Development of Distinct Types of Brain Tumors from Postnatal Neural Stem/Progenitor Cells. Cancer Research. 72(13). 3381–3392. 12 indexed citations
16.
Nannapaneni, Priyanka, Falk Hertwig, Maren Depke, et al.. (2011). Defining the structure of the general stress regulon of Bacillus subtilis using targeted microarray analysis and random forest classification. Microbiology. 158(3). 696–707. 51 indexed citations
17.
Quéré, Ronan, Göran Karlsson, Falk Hertwig, et al.. (2011). Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation. Blood. 117(22). 5918–5930. 31 indexed citations
18.
19.
Quéré, Ronan, Göran Karlsson, Falk Hertwig, et al.. (2010). SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation. Blood. 116(21). 3153–3153. 3 indexed citations
20.
Roschupkina, Teona, Falk Hertwig, Denise Kottwitz, et al.. (2007). CD133 Is Not Present on Neurogenic Astrocytes in the Adult Subventricular Zone, but on Embryonic Neural Stem Cells, Ependymal Cells, and Glioblastoma Cells. Cancer Research. 67(12). 5727–5736. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beng-Ti Ang Breakdown of academic impact, for papers by John Y.H. Kim Breakdown of academic impact, for papers by Zulekha A. Qadeer Breakdown of academic impact, for papers by Jan Gronych Breakdown of academic impact, for papers by Daniel Haag Breakdown of academic impact, for papers by Leire Moreno‐Cugnon Breakdown of academic impact, for papers by Edward Visse Breakdown of academic impact, for papers by Kanae Mitsunaga Breakdown of academic impact, for papers by Laura A. Genovesi Breakdown of academic impact, for papers by Israel Ben‐Dor
Rankless by CCL
2026